1. Home
  2. ECCC vs VRNA Comparison

ECCC vs VRNA Comparison

Compare ECCC & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECCC
  • VRNA
  • Stock Information
  • Founded
  • ECCC N/A
  • VRNA 2005
  • Country
  • ECCC United States
  • VRNA United Kingdom
  • Employees
  • ECCC N/A
  • VRNA N/A
  • Industry
  • ECCC Trusts Except Educational Religious and Charitable
  • VRNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECCC Finance
  • VRNA Health Care
  • Exchange
  • ECCC Nasdaq
  • VRNA Nasdaq
  • Market Cap
  • ECCC N/A
  • VRNA N/A
  • IPO Year
  • ECCC N/A
  • VRNA 2017
  • Fundamental
  • Price
  • ECCC $22.47
  • VRNA $81.20
  • Analyst Decision
  • ECCC
  • VRNA Strong Buy
  • Analyst Count
  • ECCC 0
  • VRNA 5
  • Target Price
  • ECCC N/A
  • VRNA $77.80
  • AVG Volume (30 Days)
  • ECCC N/A
  • VRNA 1.3M
  • Earning Date
  • ECCC N/A
  • VRNA 04-29-2025
  • Dividend Yield
  • ECCC N/A
  • VRNA N/A
  • EPS Growth
  • ECCC N/A
  • VRNA N/A
  • EPS
  • ECCC N/A
  • VRNA N/A
  • Revenue
  • ECCC N/A
  • VRNA $118,535,000.00
  • Revenue This Year
  • ECCC N/A
  • VRNA $890.44
  • Revenue Next Year
  • ECCC N/A
  • VRNA $77.74
  • P/E Ratio
  • ECCC N/A
  • VRNA N/A
  • Revenue Growth
  • ECCC N/A
  • VRNA N/A
  • 52 Week Low
  • ECCC N/A
  • VRNA $11.39
  • 52 Week High
  • ECCC N/A
  • VRNA $81.73
  • Technical
  • Relative Strength Index (RSI)
  • ECCC 54.09
  • VRNA 70.84
  • Support Level
  • ECCC $22.33
  • VRNA $73.14
  • Resistance Level
  • ECCC $22.56
  • VRNA $76.92
  • Average True Range (ATR)
  • ECCC 0.11
  • VRNA 3.43
  • MACD
  • ECCC 0.04
  • VRNA 0.66
  • Stochastic Oscillator
  • ECCC 80.33
  • VRNA 97.50

About ECCC Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031

Eagle Point Credit Co Inc. is an externally managed, non-diversified closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective of capital appreciation. The Company seeks to achieve its investment objectives by investing in equity and junior debt tranches of collateralized loan obligations ("CLOs") collateralized by a portfolio consisting of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. The Company intends to operate so as to qualify to be taxed as a regulated investment company.

Share on Social Networks: